why choose us

First received: April 24, 2023

Clinical Trial: Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: HIV Infections

Study Type: OBSERVATIONAL


Official Title: Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.

Brief Summary: The goal of this demonstration project or observational study is to evaluate the feasibility and acceptability of a pharmacist-managed cabotegravir long acting injectable for PrEP program in a community pharmacy setting.The main question it aims to answer are:Is the program feasible and acceptable at the end of 1 year of operations?What are the facilitators and barriers of the program?Participants who want to start the FDA approved cabotegravir long acting injectable medication for PrEP will have the option…

Read more